Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
3.460
-0.250 (-6.74%)
At close: Jun 24, 2026, 4:00 PM EDT
3.560
+0.100 (2.89%)
After-hours: Jun 24, 2026, 5:05 PM EDT
Inventiva Employees
As of December 31, 2025, Inventiva had 77 total employees, including 69 full-time and 8 part-time employees. The number of employees decreased by 41 or -34.75% compared to the previous year.
Employees
77
Change
-41
Growth
-34.75%
Revenue / Employee
$103,094
Profits / Employee
-$5,400,017
Market Cap
733.72M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 77 | -41 | -34.75% | 69 | 8 |
| Jun 30, 2025 | 84 | - | - | 84 | 0 |
| Dec 31, 2024 | 118 | -5 | -4.07% | 114 | 4 |
| Dec 31, 2023 | 123 | 10 | 8.85% | 120 | 3 |
| Dec 31, 2022 | 113 | 8 | 7.62% | 109 | 4 |
| Dec 31, 2021 | 105 | 11 | 11.70% | 101 | 4 |
| Mar 31, 2021 | 95 | 7 | 7.95% | 95 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CorMedix | 191 |
| Omeros | 175 |
| Allogene Therapeutics | 152 |
| Aura Biosciences | 113 |
| Vor Biopharma | 76 |
| Zevra Therapeutics | 61 |
| Oculis Holding AG | 60 |
| Design Therapeutics | 54 |
IVA News
- 8 days ago - Claret Capital Partners participates in €130m financing for Inventiva - GlobeNewsWire
- 8 days ago - Claret Capital Partners participates in €130m financing for Inventiva to support Phase 3 development - GlobeNewsWire
- 12 days ago - Inventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt Financing - GlobeNewsWire
- 15 days ago - Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents - GlobeNewsWire
- 21 days ago - Inventiva Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 22 days ago - Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris - GlobeNewsWire
- 22 days ago - Inventiva Announces a Comprehensive Capital Structure Optimization including Debt and Equity Financing in Advance of the Anticipated Phase 3 Readout - GlobeNewsWire
- 23 days ago - Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris - GlobeNewsWire